Feedback / Questions
ABTL0812 - Ability Pharma
https://www.prnewswire.com/news-releases/abilitypharma-announces--7-million-financing-round-to-advance-development-of-its-clinical-phase-2b-autophagy-inducer-abtl0812-in-metastatic-pancreatic-cancer-302085276.html
Mar 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next